Literature DB >> 34893425

Diabetes-Specific Dementia: A Structured Literature Review of Cognitive Assessment Methods.

Kelli L Faaitiiti1, Daniel C Jupiter2.   

Abstract

Diabetes mellitus is a known risk factor for the development of multiple subtypes of dementia and mild cognitive impairment. Recent research identifies a cause-specific diabetes-related dementia with a unique set of characteristics. Currently, there is no standard cognitive assessment battery recommended to specifically assess dementia that is a direct consequence of chronic diabetes, and some evaluations have been used for decades with minimal revisions, regardless of appropriateness. We performed a systematic review of the dementia/cognition evaluation methods most commonly used in the literature for assessing diabetic patients and identified which cognitive domains are typically assessed in this setting, and whether cognitive changes were more reflective of a vascular pathology, Alzheimer's pathology, or something else entirely. Search results yielded 1089 articles. After screening for appropriateness, a total of 11 full-text articles were assessed. In general, subjects in the reviewed studies were assessed using a variety of testing methods, examining different combinations of cognitive domains. A standard, clear definition of which cognitive domains are the most important to assess in diabetic patients is needed in order to determine what combination of assessment tools are most pertinent. Given the growing subset of the US population, careful reconsideration of cognitive assessment methods is needed to create self-care plans that take into account a specific collection of cognitive challenges for those with diabetes.
Copyright © 2021 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cognitive assessment screening instrument; cognitive decline; cognitive impairments; diabetes mellitus; diabetes-related complications

Mesh:

Year:  2021        PMID: 34893425      PMCID: PMC8936078          DOI: 10.1053/j.jfas.2021.11.003

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  54 in total

1.  The Trail Making Test.

Authors:  Jordi Llinàs-Reglà; Joan Vilalta-Franch; Secundino López-Pousa; Laia Calvó-Perxas; David Torrents Rodas; Josep Garre-Olmo
Journal:  Assessment       Date:  2016-07-28

2.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 3.  Early detection of cognitive disturbances in mild cognitive impairment: a systematic review of observational studies.

Authors:  Negin Chehrehnegar; Vahid Nejati; Mohsen Shati; Vahid Rashedi; Mohammadsajad Lotfi; Fatemeh Adelirad; Mahshid Foroughan
Journal:  Psychogeriatrics       Date:  2019-12-06       Impact factor: 2.440

4.  Victoria Stroop Test: normative data in a sample group of older people and the study of their clinical applications in the assessment of inhibition in Alzheimer's disease.

Authors:  Sophie Bayard; Jérôme Erkes; Christine Moroni
Journal:  Arch Clin Neuropsychol       Date:  2011-08-26       Impact factor: 2.813

5.  Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus.

Authors:  Ji Chen; Junxiang Zhang; Xuebing Liu; Xiaoyang Wang; Xiangjin Xu; Hui Li; Bo Cao; Yanqiu Yang; Jingjing Lu; Ziqian Chen
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

6.  Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study.

Authors:  Alexandra M V Wennberg; Clinton E Hagen; Rebecca F Gottesman; Vadim Zipunnikov; Christopher N Kaufmann; Marilyn S Albert; George W Rebok; Judith D Kasper; Adam P Spira
Journal:  Arch Gerontol Geriatr       Date:  2017-05-16       Impact factor: 3.250

7.  MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.

Authors:  Sarah T Pendlebury; Jose Mariz; Linda Bull; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2011-12-08       Impact factor: 7.914

8.  Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.

Authors:  José A Luchsinger; Yong Ma; Costas A Christophi; Hermes Florez; Sherita H Golden; Helen Hazuda; Jill Crandall; Elizabeth Venditti; Karol Watson; Susan Jeffries; Jennifer J Manly; F Xavier Pi-Sunyer
Journal:  Diabetes Care       Date:  2017-05-12       Impact factor: 19.112

Review 9.  Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing.

Authors:  Judith Jaeger
Journal:  J Clin Psychopharmacol       Date:  2018-10       Impact factor: 3.153

10.  Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes.

Authors:  Chen-Chih Chung; Daniela Pimentel; Azizah J Jor'dan; Ying Hao; William Milberg; Vera Novak
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.